25 May 2013
Keywords: pozen, cuts, loss, attracts, zacks, interest, north
Article | 06 May 2009
Pozen, a North Carolina, USA-based drug developer, has posted a 53% reduction in loss, year-on-year, on increasing revenue, slightly ahead of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.